SLGC
Somalogic Inc
NASDAQ: SLGC · HEALTHCARE · HEALTH INFORMATION SERVICES
$9.90
+0.00% today
Updated 2026-05-28
Market cap
$396.23M
P/E ratio
—
P/S ratio
4.85x
EPS (TTM)
$-0.69
Dividend yield
—
52W range
$19 – $20
Volume
0.0M
WallStSmart proprietary scores
29
out of 100
Grade: F
Strong Sell
Investment rating
4.7
Growth
C5.0
Quality
C+2.0
Profitability
F5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →199 stocks currently score above 75
Price targets
Analyst target
$3.93
-60.32%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Thin margins at -159.50%
- Negative free cash flow $-121.89M
- Revenue declining -47.10% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2020 | 2021 | 2022 | 2023 | TTM |
|---|---|---|---|---|---|
| Revenue | $55.89M | $81.63M | $97.67M | $81.72M | $81.72M |
| Net income | $-71.35M | $-86.30M | $-109.16M | $-130.38M | $-130.38M |
| EPS | — | — | — | — | $-0.69 |
| Free cash flow | $-29.50M | $-43.70M | $-105.88M | $-121.89M | $-121.89M |
| Profit margin | -127.67% | -105.73% | -111.77% | -159.54% | -159.50% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2024-01-05 | TAICH, ADAM | Sale | 855,000 | — |
| 2024-01-05 | TAICH, ADAM | Sale | 185,812 | — |
| 2024-01-05 | TAICH, ADAM | Sale | 150,000 | — |
Peer comparison
Smart narrative
Somalogic Inc trades at $9.90. Our Smart Value Score of 29/100 indicates the stock is weak. TTM revenue stands at $81.72M. with profit margins at -159.50%.
Frequently asked questions
What is Somalogic Inc's stock price?
Somalogic Inc (SLGC) trades at $9.90, on a P/S of 4.8x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Somalogic Inc overvalued?
Somalogic Inc carries a Smart Value Score of 29/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Somalogic Inc (SLGC)?
The 12-month analyst consensus target is $3.93, about 60.3% below the current $9.90. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Somalogic Inc's revenue?
Somalogic Inc's trailing twelve-month revenue is $81.72M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Company info
SectorHEALTHCARE
IndustryHEALTH INFORMATION SERVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio4.85x
ROE-23.70%
Beta1.64
50D MA$2.43
200D MA$2.45
Shares out0.19B
Float0.15B
Short ratio—
Avg volume0.0M
Performance
1 week+0.00%
1 month+0.20%
3 months+0.71%
YTD+371.90%
1 year+371.90%
3 years—
5 years—